Kosik K S, Qiu W Q, Greenberg S
Harvard Medical School, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
Ann N Y Acad Sci. 1996 Jan 17;777:114-20. doi: 10.1111/j.1749-6632.1996.tb34409.x.
We describe a possible mechanism by which the amyloid precursor protein (APP) may be linked to the intraneuronal pathology of Alzheimer's disease (AD). Extracellular proteolytic products of APP may directly or indirectly transduce signals to cells under normal as well as pathological conditions. This activity appears to reside in the cysteine-rich amino terminus of APP. How APP or its metabolic products may affect the phosphorylation of tau is considered.
我们描述了一种可能的机制,通过该机制淀粉样前体蛋白(APP)可能与阿尔茨海默病(AD)的神经元内病理学相关联。在正常以及病理条件下,APP的细胞外蛋白水解产物可能直接或间接地将信号传导至细胞。这种活性似乎存在于APP富含半胱氨酸的氨基末端。我们还考虑了APP或其代谢产物如何影响tau蛋白的磷酸化。